10
Participants
Start Date
December 2, 2022
Primary Completion Date
September 30, 2025
Study Completion Date
December 31, 2025
In vitro culture of autologous dendritic and natural killer cells for the treatment of patients with non-small cell lung cancer
The primary objective of this trial is to test the safety of formulations containing dendritic cells (DCs) and natural killer (NK) cells cultured in vitro. By evaluating the reactions following the administration of autologous dendritic cells via axillary lymph node injection and natural killer cells via intravenous injection, the study aims to determine the safety profile of these trial products for human use.
RECRUITING
National Taiwan University Hospital Yunlin Branch, Huwei
National Taiwan University Hospital, Yun-Lin Branch
OTHER
National Taiwan University Clinical Trial Center
OTHER